Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.06 - Poster Session 1 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 59
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.06-053 - Clinical utility of circulating serum and plasma biomarkers for personalised radiotherapy treatment of non-small cell lung cancer (NSCLC)
09:30 - 09:30 | Author(s): C. Faivre-Finn
- Abstract
Loading...
-
+
P1.09 - Poster Session 1 - Combined Modality
- Type: Poster Session
- Track: Combined Modality
- Presentations: 22
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.09-011 - Phase I clinical trial assessing the MEK inhibitor selumetinib (AZD6244; ARRY-142886) with concomitant thoracic radiotherapy (RT) in patients with Stage III-IV non small cell lung cancer (NSCLC)
09:30 - 09:30 | Author(s): A. Fusi
- Abstract
Loading...
-
+
MO07 - NSCLC - Targeted Therapies II
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 14
- Moderators:T. John
- Coordinates: 10/28/2013, 16:15 - 17:45, Bayside Auditorium B, Level 1
-
+
MO07.11 - A randomised placebo-controlled multicentre phase II trial of erlotinib plus whole brain radiotherapy for patients with advanced non-small cell lung cancer with multiple brain metastases (TACTIC)
17:15 - 17:20 | Author(s): S.M. Lee
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.09 - Poster Session 2 - Combined Modality
- Type: Poster Session
- Track: Combined Modality
- Presentations: 18
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.09-008 - Concurrent chemoradiotherapy (cCTRT) for locally advanced Non Small Cell Lung Cancer (NSCLC) followed by consolidation Pemetrexed: a phase II study
09:30 - 09:30 | Author(s): C. Faivre-Finn
- Abstract
Loading...
-
+
P2.24 - Poster Session 2 - Supportive Care
- Type: Poster Session
- Track: Supportive Care
- Presentations: 61
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.24-034 - Treatment Beyond Progression in Patients with Non-Small Cell Lung Cancer Harbouring EGFR Mutations - The Manchester Lung Cancer Group Experience
09:30 - 09:30 | Author(s): E. Halkyard
- Abstract
Loading...
-
+
O14 - Radiotherapy - Toxicity and Clinical Trials
- Type: Oral Abstract Session
- Track: Radiation Oncology + Radiotherapy
- Presentations: 8
- Moderators:G. Pratt
- Coordinates: 10/29/2013, 10:30 - 12:00, Parkside Ballroom A, Level 1
-
+
O14.06 - Investigation of a Patient Reported Outcome (PRO) tool to assess radiotherapy-related toxicity in patients with lung cancer
11:25 - 11:35 | Author(s): M. Christodoulou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.11 - Poster Session 3 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 52
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.11-024 - QUARTZ
Quality of Life after Treatment for Brain Metastases from Non-Small Cell Lung Cancer: An update on the UK Medical Research Council QUARTZ trial.09:30 - 09:30 | Author(s): P.M. Mulvenna
- Abstract
Loading...
-
+
P3.13 - Poster Session 3 - SCLC
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 8
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.13-005 - CONVERT - the challenges of opening centres and recruiting patients to an international multi-centre chemo-radiotherapy trial in limited-stage small cell lung cancer
09:30 - 09:30 | Author(s): C. Faivre-Finn
- Abstract
Loading...
-
+
MO23 - Radiotherapy II: Lung Toxicity, Target Definition and Quality Assurance
- Type: Mini Oral Abstract Session
- Track: Radiation Oncology + Radiotherapy
- Presentations: 12
- Moderators:M.M. Tin
- Coordinates: 10/30/2013, 10:30 - 12:00, Bayside 204 A+B, Level 2
-
+
MO23.04 - Is pre-trial quality assurance (QA) effective? A comparison of pre-trial QA versus ongoing QA for the CONVERT Trial.
10:50 - 10:55 | Author(s): N. Groom
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MO23.05 - Changes in lung radiotherapy techniques during the CONVERT Trial. A survey of participating centres.
10:45 - 10:50 | Author(s): N. Groom
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MS20 - Small Cell Lung Cancer
- Type: Mini Symposia
- Track: Medical Oncology
- Presentations: 5
- Moderators:N. Murray
- Coordinates: 10/30/2013, 14:00 - 15:30, Bayside 204 A+B, Level 2
-
+
MS20.3 - Optimal Radiotherapy for SCLC
14:45 - 15:05 | Author(s): C. Faivre-Finn
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
